Susceptibilities to amphotericin B and fluconazole of Candida species in Taiwan Surveillance of Antimicrobial Resistance of Yeasts 2006

被引:52
作者
Yang, Yun-Liang [2 ]
Wang, An-Huei [1 ]
Wang, Chih-Wei [1 ]
Cheng, Wei-Ting [1 ]
Li, Shu-Ying [3 ]
Lo, Hsiu-Jung [1 ]
机构
[1] Natl Hlth Res Inst, Div Clin Res, Zhunan Town 350, Miaoli Cty, Taiwan
[2] Natl Chiao Tung Univ, Dept Biol Sci & Technol, Hsinchu 300, Taiwan
[3] Ctr Dis Control, Div Lab Res & Dev, Taipei 115, Taiwan
关键词
Candida; susceptibility; resistance;
D O I
10.1016/j.diagmicrobio.2008.01.011
中图分类号
R51 [传染病];
学科分类号
100401 ;
摘要
Susceptibilities to amphotericin B and fluconazole of 964 Candida isolates collected in Taiwan Surveillance of Antimicrobial Resistance of Yeasts in 2006 were determined. There were 419 (43.5%) Candida albicans, 246 (25.5%) Candida tropicalis, 211 (21.9%) Candida glabrata, 62 (6.4%) Candida parapsilosis, 14 (1.5%) Candida krusei, and 12 (1.2%) others. Interestingly, 16 of the 17 amphotericin B-resistant isolates were non-albicans Candida species. The resistant rate to amphotericin B has decreased from 2.5% in 2002 to 1.8% in 2006. On the other hand, there were 132 C. tropicalis, 14 C. krusei, 10 C. albicans, and 9 C. glabrata isolates that had MICs to fluconazole >= 64 mu g/mL. The prevalence of isolates with such high MICs was significantly higher than that in 2002 (17.1% versus 1.9%). Our results further indicate that most of the isolates with MICs to fluconazole >= 64 mu g/mL exhibited the "trailing" phenomenon. (C) 2008 Elsevier Inc. All rights reserved.
引用
收藏
页码:175 / 180
页数:6
相关论文
共 50 条
  • [1] Susceptibilities to amphotericin B and fluconazole of Candida species in TSARY 2002
    Yang, YL
    Li, SY
    Cheng, HH
    Lo, HJ
    DIAGNOSTIC MICROBIOLOGY AND INFECTIOUS DISEASE, 2005, 51 (03) : 179 - 183
  • [2] MUTANTS WITH HETERORESISTANCE TO AMPHOTERICIN B AND FLUCONAZOLE IN CANDIDA
    Claudino, A. L. R.
    Peixoto Junior, R. F.
    Melhem, M. S. C.
    Szeszs, M. W.
    Lyon, J. P.
    Chavasco, J. K.
    Franco, M. C.
    BRAZILIAN JOURNAL OF MICROBIOLOGY, 2009, 40 (04) : 943 - 951
  • [3] Activities of Fluconazole, Caspofungin, Anidulafungin, and Amphotericin B on Planktonic and Biofilm Candida Species Determined by Microcalorimetry
    Maiolo, Elena Maryka
    Tafin, Ulrika Furustrand
    Borens, Olivier
    Trampuz, Andrej
    ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 2014, 58 (05) : 2709 - 2717
  • [4] Susceptibilities to Amphotericin B, Fluconazole and Voriconazole of Trichosporon Clinical Isolates
    Tsai, Moan Shane
    Yang, Yun Liang
    Wang, An Huei
    Wang, Lih Shinn
    Lu, Daniel C. T.
    Liou, Ci Hong
    Hsieh, Li Yun
    Wu, Chi Jung
    Cheng, Ming Fang
    Shi, Zhi Yuan
    Lo, Hsiu Jung
    MYCOPATHOLOGIA, 2012, 174 (02) : 121 - 130
  • [5] In Vitro Susceptibilities of Non-albicans Candida Species to Echinocandins, Azoles, and Amphotericin B in Tokat, Turkey
    Yenisehirli, Gulgun
    Ozveren, Gulsen
    Yenisehirli, Aydan
    Bulut, Yunus
    JUNDISHAPUR JOURNAL OF MICROBIOLOGY, 2018, 11 (06)
  • [6] Amphotericin B and fluconazole susceptibility of Candida species determined by cell-chip technology
    Bouquet, Orsolya
    Kocsis, Bela
    Kilar, Ferenc
    Lorand, Tamas
    Kustos, Ildiko
    MYCOSES, 2012, 55 (03) : e90 - e96
  • [7] Role of yeasts as nosocomial pathogens & their susceptibility to fluconazole & amphotericin B
    Prasad, KN
    Agarwal, J
    Dixit, AK
    Tiwari, DP
    Dhole, TN
    Ayyagari, A
    INDIAN JOURNAL OF MEDICAL RESEARCH, 1999, 110 : 11 - 17
  • [8] Candida bracarensis: Evaluation of Virulence Factors and its Tolerance to Amphotericin B and Fluconazole
    Moreira, Andre
    Silva, Sonia
    Botelho, Claudia
    Sampaio, Paula
    Pais, Celia
    Henriques, Mariana
    MYCOPATHOLOGIA, 2015, 180 (5-6) : 305 - 315
  • [9] Transcriptional response to fluconazole and amphotericin B in Candida albicans biofilms
    Nailis, Heleen
    Vandenbosch, Davy
    Deforce, Dieter
    Nelis, Hans J.
    Coenye, Tom
    RESEARCH IN MICROBIOLOGY, 2010, 161 (04) : 284 - 292
  • [10] In vitro activity of a new echinocandin, LY303366, and comparison with fluconazole, flucytosine and amphotericin B against Candida species
    Moore, CB
    Oakley, KL
    Denning, DW
    CLINICAL MICROBIOLOGY AND INFECTION, 2001, 7 (01) : 11 - 16